Barclays’s Contineum Therapeutics CTNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7K | Sell |
1,732
-9,351
| -84% | -$37.8K | ﹤0.01% | 4188 |
|
|
2025
Q1 | $77K | Sell |
11,083
-5,203
| -32% | -$36.1K | ﹤0.01% | 3765 |
|
|
2024
Q4 | $239K | Buy |
16,286
+7,978
| +96% | +$117K | ﹤0.01% | 3432 |
|
|
2024
Q3 | $158K | Buy |
8,308
+5,925
| +249% | +$113K | ﹤0.01% | 3592 |
|
|
2024
Q2 | $42K | Buy |
+2,383
| New | +$42K | ﹤0.01% | 3744 |
|